French based Mistral Warbirds brought back a legend to the sky of Europe: this legend is the North American F-86 Sabre (Canadair CL-13B Sabre Mk6) first generation, swept-wing transonic jet fighter aircraft, manufactured by North American Aviation and by Canadair under licence from North American Aviation from the late 40s. The aircraft has countries as former operators in Europe like Belgium, Germany, Denmark, Portugal or Spain.
In the United States of America, there are about 10 F-86’s airworthy from the A and F variants, almost all of them are privately owned. Besides the United States, the F-86s can still be viewed in airworthy condition in Australia, Canada and South Africa. This Sabre will be the first aircraft in Europe after the return of the FU-178 callsigned Sabre, resident in the UK since 1991 to 2014 and was until recently operated by the Golden Apple Operations
The French Sabre – FU-675
The aircraft bought from the United States of America and for the French team, it took eighteen months to bring the aircraft (N80FS Canadair CL-13B Sabre Mk6) to flight status, and the first flight was made on 3rd of May. The aircraft is painted unusually, in gray-green camouflage. This was the experimental painting used in the 461st US Air Force Day Fighter Squadron when stationed in Europe in the 1950s and 1960s.
Originally the aircraft belonged to the Luftwaffe as S6-1675 (later JD+103, BB+284, then KE+104), flied in the UK from 1977 to 1979 and brought back to Canada in 1979. After a long time the aircraft get in airworthy from 2010.
The Fu-675 already debuted in France, at the La Ferté Alais oldtimer airshow. Now the team confirmed that they plan to participate on AirPower’19 in Zeltweg, Austria and perform flying display with the legendary Sabre aircraft. AirPower always had strong historic flight line up, the visitors of the event in the past were able to see the Messerschmitt BF-109 or ME-262, the MiG-15UTI, the aircrafts of the Swedish Air Force Historic Flight (Viggen, Draken, Tunnan) or the legendary Fokker Dr.I.